Levomepromazine vs atypical antipsychotics
Leaving the study early ‐ short term ‐ due to patient deterioration · patients with schizophrenia
Levomepromazine showed no clear difference in leaving the study early ‐ short term ‐ due to patient deterioration compared with atypical antipsychotics (moderate certainty).
1 finding from 1 review
- RR 5 [0.25, 98.27]1 study · 42 participantsModerate